SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein

被引:478
作者
Nakamura, K
Jeong, SY
Uchihara, T
Anno, M
Nagashima, K
Nagashima, T
Ikeda, S
Tsuji, S
Kanazawa, I
机构
[1] Univ Tokyo, Grad Sch Med, Div Neurosci, Dept Neurol,Bunkyo Ku, Tokyo 1138655, Japan
[2] Japan Sci & Technol Corp, CREST, Tokyo, Japan
[3] Tokyo Metropolitan Inst Neurosci, Dept Neuropathol, Tokyo 1838526, Japan
[4] Tokyo Metropolitan Matsuzawa Hosp, Dept Neurol, Setagaya Ku, Tokyo 1560057, Japan
[5] Hokkaido Univ, Sch Med, Lab Mol & Cellular Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[6] Teine Keijinkai Hosp, Dept Neurol, Sapporo, Hokkaido, Japan
[7] Shinshu Univ, Sch Med, Dept Internal Med 3, Matsumoto, Nagano 3908621, Japan
[8] Niigata Univ, Inst Brain Res, Dept Neurol, Niigata 9518585, Japan
关键词
D O I
10.1093/hmg/10.14.1441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genetic etiologies of at least 20% of autosomal dominant cerebellar ataxias (ADCAs) have yet to be clarified. We identified a novel spinocerebellar ataxia (SCA) form in four Japanese pedigrees which is caused by an abnormal CAG expansion in the TATA-binding protein (TBP) gene, a general transcription initiation factor. Consequently, it has been added to the group of polyglutamine diseases. This abnormal expansion of glutamine tracts in TBP bears 47-55 repeats, whereas the normal repeat number ranges from 29 to 42. Immunocytochemical examination of a postmortem brain which carried 48 CAG repeats detected neuronal intranuclear inclusion bodies that stained with anti-ubiquitin antibody, anti-TBP antibody and with the 1C2 antibody that recognizes specifically expanded pathological polyglutamine tracts. We therefore propose that this new disease be called SCA17 (TBP disease).
引用
收藏
页码:1441 / 1448
页数:8
相关论文
共 37 条
[1]   Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin [J].
Boutell, JM ;
Thomas, P ;
Neal, JW ;
Weston, VJ ;
Duce, J ;
Harper, PS ;
Jones, AL .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1647-1655
[2]   Transcriptional dysregulation in Huntington's disease [J].
Cha, JHJ .
TRENDS IN NEUROSCIENCES, 2000, 23 (09) :387-392
[3]   Fourteen and counting: unraveling trinucleotide repeat diseases [J].
Cummings, CJ ;
Zoghbi, HY .
HUMAN MOLECULAR GENETICS, 2000, 9 (06) :909-916
[4]   Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? [J].
Davies, SW ;
Beardsall, K ;
Turmaine, M ;
DiFiglia, M ;
Aronin, N ;
Bates, GP .
LANCET, 1998, 351 (9096) :131-133
[5]   PHENOTYPIC VARIABILITY IN AUTOSOMAL-DOMINANT CEREBELLAR-ATAXIA TYPE-I IS UNRELATED TO GENETIC-HETEROGENEITY [J].
DURR, A ;
CHNEIWEISS, H ;
KHATI, C ;
STEVANIN, G ;
CANCEL, G ;
FEINGOLD, J ;
AGID, Y ;
BRICE, A .
BRAIN, 1993, 116 :1497-1508
[6]   Identification of genes that modify ataxin-1-induced neurodegeneration [J].
Fernandez-Funez, P ;
Nino-Rosales, ML ;
de Gouyon, B ;
She, WC ;
Luchak, JM ;
Martinez, P ;
Turiegano, E ;
Benito, J ;
Capovilla, M ;
Skinner, PJ ;
McCall, A ;
Canal, I ;
Orr, HT ;
Zoghbi, HY ;
Botas, J .
NATURE, 2000, 408 (6808) :101-106
[7]  
GOSTOUT B, 1993, AM J HUM GENET, V52, P1182
[8]   TBP-associated factors (TAFIIs):: multiple, selective transcriptional mediators in common complexes [J].
Green, MR .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (02) :59-63
[9]  
HARDING AE, 1993, ADV NEUROL, V61, P1
[10]   Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins [J].
Huang, CC ;
Faber, PW ;
Persichetti, F ;
Mittal, V ;
Vonsattel, JP ;
MacDonald, ME ;
Gusella, JF .
SOMATIC CELL AND MOLECULAR GENETICS, 1998, 24 (04) :217-233